Morgan Stanley is Awaiting Approvals and M&A on Mylan in the Wake of P/E Re-Rating
February 28, 2014 at 10:30 AM EST
In a report published Friday, Morgan Stanley analyst David Risinger reiterated an Equal-Weight rating on Mylan (NASDAQ: MYL ). In the report, Morgan Stanley noted, “MYL's multiple has re-rated; we see a balanced risk-reward ahead of NT binary events. MYL shares are currently trading at 16x our 2014E EPS of